{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:56:56Z","timestamp":1784581016345,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jgar.2025.10.022","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:20:51Z","timestamp":1761697251000},"page":"329-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Risk factors for mortality in Elizabethkingia spp. bloodstream infections"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-7281","authenticated-orcid":false,"given":"Jinghao Nicholas","family":"Ngiam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7374-8207","authenticated-orcid":false,"given":"Matthew Chung Yi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1332-7884","authenticated-orcid":false,"given":"Tiara Joy","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-1258","authenticated-orcid":false,"given":"David Michael","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Lip","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2025.10.022_bib0001","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3390\/jcm9051431","article-title":"Risk factors for mortality in patients with Elizabethkingia infection and the clinical impact of the antimicrobial susceptibility patterns of Elizabethkingia species","volume":"9","author":"Seong","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jgar.2025.10.022_bib0002","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jhin.2014.01.009","article-title":"Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections","volume":"86","author":"Jean","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2025.10.022_bib0003","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12879-025-10636-9","article-title":"Clinical presentation and outcomes of bloodstream infection with intrinsically carbapenem-resistant non-fermenting gram-negative organisms: Stenotrophomonas maltophilia, elizabethkingia spp. And chryseobacterium spp. in Singapore, from 2012 to 2024","volume":"25","author":"Koh","year":"2025","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2025.10.022_bib0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3201\/eid2501.171985","article-title":"Risk factors for Elizabethkingia acquisition and clinical characteristics of patients, South Korea","volume":"25","author":"Choi","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2025.10.022_bib0005","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(13)61858-9","article-title":"First case of E anophelis outbreak in an intensive-care unit","volume":"382","author":"Teo","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.jgar.2025.10.022_bib0006","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/cid\/cix1052","article-title":"Elizabethkingia in children: a comprehensive review of symptomatic cases reported from 1944 to 2017","volume":"67","author":"Dziuban","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2025.10.022_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01445-17","article-title":"Elizabethkingia anophelis is the dominant Elizabethkingia species found in blood cultures in Singapore","volume":"56","author":"Chew","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2025.10.022_bib0008","unstructured":"EUCAST: European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints\u2014Breakpoints and guidance. https:\/\/www.eucast.org\/clinical_breakpoints (Date Accessed 19\/7\/2024)."},{"key":"10.1016\/j.jgar.2025.10.022_bib0009","series-title":"M100, performance standards for antimicrobial susceptibility testing","year":"2023"},{"key":"10.1016\/j.jgar.2025.10.022_bib0010","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/jac\/dkaa499","article-title":"Susceptibility of Elizabethkingia spp. To commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods","volume":"76","author":"Kuo","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.10.022_bib0011","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/jac\/dkad322","article-title":"In vitro and in vivo evidence discourages routine testing and reporting of piperacillin\/tazobactam susceptibility of Elizabethkingia species","volume":"79","author":"Tan","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.10.022_bib0012","doi-asserted-by":"crossref","first-page":"e00730","DOI":"10.1128\/JCM.00730-20","article-title":"Comparative genomics and antimicrobial resistance profiling of Elizabethkingia isolates reveal nosocomial transmission and in vitro susceptibility to fluoroquinolones, tetracyclines, and trimethoprim-sulfamethoxazole","volume":"58","author":"Burnard","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2025.10.022_bib0013","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1093\/jac\/dky197","article-title":"Clinical manifestations, molecular characteristics, antimicrobial susceptibility patterns and contributions of target gene mutation to fluoroquinolone resistance in Elizabethkingia anophelis","volume":"73","author":"Lin","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.10.022_bib0014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12941-024-00691-6","article-title":"Clinical manifestations, antimicrobial resistance and genomic feature analysis of multidrug-resistant Elizabethkingia strains","volume":"23","author":"Wu","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2025.10.022_bib0015","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3390\/microorganisms10050882","article-title":"Epidemiology and characteristics of Elizabethkingia spp. Infections in Southeast Asia","volume":"10","author":"Zajmi","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.jgar.2025.10.022_bib0016","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/jac\/dkab018","article-title":"Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anophelis","volume":"76","author":"Tang","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.10.022_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02495-18","article-title":"A systematic review and meta-analysis of antibiotic treatment duration for bacteremia due to Enterobacteriaceae","volume":"63","author":"Tansarli","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.10.022_bib0018","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijantimicag.2019.05.011","article-title":"Duration of therapy recommended for bacteraemic illness varies widely amongst clinicians","volume":"54","author":"Alwan","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2025.10.022_bib0019","doi-asserted-by":"crossref","first-page":"e00301","DOI":"10.1128\/aac.00301-22","article-title":"Mutant prevention concentrations of ciprofloxacin and levofloxacin and target gene mutations of fluoroquinolones in Elizabethkingia anophelis","volume":"66","author":"Lin","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.10.022_bib0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10096-017-2942-7","article-title":"Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan","volume":"36","author":"Huang","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2025.10.022_bib0021","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1099\/jmm.0.001021","article-title":"Invasive paediatric Elizabethkingia meningoseptica infections are best treated with a combination of piperacillin\/tazobactam and trimethoprim\/sulfamethoxazole or fluoroquinolone","volume":"68","author":"Chan","year":"2019","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jgar.2025.10.022_bib0022","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/mdr.2019.0260","article-title":"Correlation between Etest and reference broth microdilution for antimicrobial susceptibility testing of Burkholderia pseudomallei","volume":"26","author":"Lonsway","year":"2020","journal-title":"Microb Drug Resist"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525002401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525002401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T22:04:53Z","timestamp":1780783493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716525002401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":22,"alternative-id":["S2213716525002401"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.10.022","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for mortality in Elizabethkingia spp. bloodstream infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}